Maternal Health Care and Pregnancy Outcomes in Undocumented Migrant Women in Norway.
Launched by UNIVERSITY OF OSLO · Jun 22, 2020
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the health care needs and pregnancy outcomes of undocumented migrant women in Norway. Researchers want to learn more about how these women access health services and whether not having a registered identity number affects their health during pregnancy and after childbirth. The study will compare the experiences of undocumented pregnant migrants with those of other migrants and Norwegian women, helping to uncover important trends and outcomes related to maternal and perinatal health in this group.
To be eligible for this trial, participants must be female and not have a registered Norwegian identity number. The trial is not yet recruiting participants, but once it begins, eligible women can expect to receive care and support at voluntary and emergency clinics in Oslo and Bergen. This research is important because it aims to fill a gap in knowledge about a population that is often overlooked in health studies, and it will help improve health care for undocumented migrant women in Norway.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • No registered Norwegian identity number
- • Female
- Exclusion Criteria:
- • Male
About University Of Oslo
The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Cecilie Dahl, PhD, MPH
Principal Investigator
University of Oslo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials